Amarin Corporation PLC
NASDAQ:AMRN

Watchlist Manager
Amarin Corporation PLC Logo
Amarin Corporation PLC
NASDAQ:AMRN
Watchlist
Price: 16.54 USD 0.49% Market Closed
Market Cap: 343.9m USD

Amarin Corporation PLC
Cash from Investing Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Amarin Corporation PLC
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Amarin Corporation PLC
NASDAQ:AMRN
Cash from Investing Activities
-$10.7m
CAGR 3-Years
N/A
CAGR 5-Years
52%
CAGR 10-Years
-101%
Alkermes Plc
NASDAQ:ALKS
Cash from Investing Activities
-$40.8m
CAGR 3-Years
24%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Prothena Corporation PLC
NASDAQ:PRTA
Cash from Investing Activities
-$181k
CAGR 3-Years
33%
CAGR 5-Years
2%
CAGR 10-Years
8%
M
Mural Oncology PLC
NASDAQ:MURA
Cash from Investing Activities
-$25.3m
CAGR 3-Years
-79%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Amarin Corporation PLC
Glance View

Market Cap
344m USD
Industry
Biotechnology

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics for cardiovascular disease management. The firm operates through the development and commercialization of Vascepa segment. Its lead product, Vascepa (icosapent ethyl) capsule for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

AMRN Intrinsic Value
22.15 USD
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Amarin Corporation PLC's Cash from Investing Activities?
Cash from Investing Activities
-10.7m USD

Based on the financial report for Sep 30, 2025, Amarin Corporation PLC's Cash from Investing Activities amounts to -10.7m USD.

What is Amarin Corporation PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-101%

Over the last year, the Cash from Investing Activities growth was 89%.

Back to Top